Mild hypothermia is a well-established treatment for babies at risk from long-term brain damage following a lack of oxygen at birth. Doctors would like to tailor the treatment to individual cases and predict long-term outcomes. To this end, two studies published in Pediatric Research investigate ways to guide therapy; the first identifies brain metabolites in a mouse model; the second tests a combination of two bedside monitoring techniques. We hear from authors of both studies on this month's podcast.

Hosted on Acast. See acast.com/privacy for more information.